We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$43B
AUM Growth
-$7.89B
(-16%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
8,577
New
1,058
Increased
2,469
Reduced
3,270
Closed
1,444
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$158M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 4 |
Boeing
BA
|
+$34.1M |
| 5 |
ARK Innovation ETF
ARKK
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$128M |
| 2 |
NVIDIA
NVDA
|
+$89M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.6M |
| 5 |
Biogen
BIIB
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.37% |
| 2 | Healthcare | 1.33% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Energy | 0.65% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
CALL
CytomX Therapeutics
CTMX
$750M
| $20.8K | ﹤0.01% |
13,000
+11,300
| +665% | +$16.7K |
|
5577
CALL
Expeditors International
EXPD
$23.3B
| $20.8K | ﹤0.01% |
+200
| New | +$20.6K |
|
5578
CALL
Arlo Technologies
ARLO
$1.6B
| $20.7K | ﹤0.01% |
5,900
+900
| +18% | +$3.7K |
|
5579
CALL
Stereotaxis
STXS
$143M
| $20.7K | ﹤0.01% |
10,000
-31,900
| -76% | -$62.3K |
|
|
SUNW
5580
PUT
DELISTED
Sunworks, Inc.
SUNW
| $20.7K | ﹤0.01% |
13,100
-9,600
| -42% | -$21.5K |
|
|
PACW
5581
CALL
DELISTED
PacWest Bancorp
PACW
| $20.7K | ﹤0.01% |
900
-10,000
| -92% | -$243K |
|
|
APTO
5582
DELISTED
Aptose Biosciences, Inc.
APTO
| $20.6K | ﹤0.01% |
79
-62
| -44% | -$16.7K |
|
|
SEAC
5583
PUT
DELISTED
Seachange International Inc
SEAC
| $20.6K | ﹤0.01% |
2,185
-17,755
| -89% | -$151K |
|
|
MREO
5584
PUT
Mereo BioPharma
MREO
$43.5M
| $20.6K | ﹤0.01% |
27,400
| – | – |
|
5585
CALL
Westlake Corp
WLK
$10.1B
| $20.5K | ﹤0.01% |
200
-100
| -33% | -$10.1K |
|
5586
INNOVATE Corp
VATE
$97.3M
| $20.5K | ﹤0.01% |
1,095
-7,748
| -88% | -$81.6K |
|
5587
Replimune Group
REPL
$1.15B
| $20.4K | ﹤0.01% |
+750
| New | +$15.6K |
|
5588
PUT
Rhythm Pharmaceuticals
RYTM
$7.95B
| $20.4K | ﹤0.01% |
700
+200
| +40% | +$5.14K |
|
5589
PUT
Pembina Pipeline
PBA
$27.8B
| $20.4K | ﹤0.01% |
600
-2,400
| -80% | -$80.5K |
|
5590
CALL
Lineage Cell Therapeutics
LCTX
$286M
| $20.2K | ﹤0.01% |
17,300
-30,900
| -64% | -$38.9K |
|
|
FIRY
5591
PUT
Firy Inc
FIRY
$164M
| $20.2K | ﹤0.01% |
1,995
-1,515
| -43% | -$27.8K |
|
5592
PUT
Extreme Networks
EXTR
$3.09B
| $20.1K | ﹤0.01% |
1,100
-7,100
| -87% | -$124K |
|
5593
Cimpress
CMPR
$2.29B
| $20.1K | ﹤0.01% |
+729
| New | +$18.9K |
|
5594
X4 Pharmaceuticals
XFOR
$421M
| $20K | ﹤0.01% |
673
-423
| -39% | -$20K |
|
5595
CALL
Maravai LifeSciences
MRVI
$895M
| $20K | ﹤0.01% |
1,400
-2,200
| -61% | -$34.6K |
|
|
IPG
5596
PUT
DELISTED
Interpublic Group of Companies
IPG
| $20K | ﹤0.01% |
600
+100
| +20% | +$3.1K |
|
5597
Viavi Solutions
VIAV
$9.18B
| $20K | ﹤0.01% |
+1,900
| New | +$22.9K |
|
5598
CALL
Cooper-Standard Automotive
CPS
$504M
| $19.9K | ﹤0.01% |
2,200
+1,500
| +214% | +$10.6K |
|
5599
CALL
Addus HomeCare
ADUS
$2.23B
| $19.9K | ﹤0.01% |
+200
| New | +$20.9K |
|
5600
CALL
New Jersey Resources
NJR
$5.45B
| $19.8K | ﹤0.01% |
400
-3,800
| -90% | -$174K |
|
Similar funds
SCP
RIM
Group One Trading's Q4 2022 Portfolio in Review
As of Q4 2022, Group One Trading held 8,577 positions worth $43B, down 16% from $50.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading withdrew a net $3.97B in Q4 2022, closing 1,444 positions and reducing 3,270 holdings. Its most notable exit was Biogen, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Cigna worth $165M.
- Group One Trading's largest Q4 2022 buy was Cigna: 497,989 shares worth $165M.
- Group One Trading added most to Microsoft in Q4 2022, an estimated $62.9M increase.
- Group One Trading's biggest Q4 2022 reduction was Tesla, cutting an estimated $128M.
- Group One Trading fully exited Biogen in Q4 2022, selling an estimated $30.6M.
- Group One Trading's ten largest holdings make up 22% of its $43B portfolio in Q4 2022.
- Group One Trading opened 1,058 new positions and closed 1,444 in Q4 2022.
- Group One Trading's portfolio value fell 16% quarter-over-quarter to $43B.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.